Loading clinical trials...

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia | Clinical Trials | Clareo Health

UNKNOWNPHASE4

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)

NCT06061393•Western Galilee Hospital-Nahariya

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Eligibility

Age

18 - 50 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•pregnancy\>24 weeks of gestation anemia with Hb\<8 anemia with Hb\<9 if symptomatic anemia of previous postpartum hemorrhage

Exclusion Criteria

•Allergy to one of the study's drugs
•IV iron treatment in the last month
•chronic anemia- thalassemia, renal failure Twins pregnancy
•non iron deficiency anemia

Key Dates

Start Date

October 30, 2023

Primary Completion Date

September 20, 2025

Completion Date

September 20, 2025

Last Updated

October 6, 2023

Enrollment

200

ESTIMATED participants

Conditions

Anemia, Iron DeficiencyPregnancy Anemia

Interventions

Venofer 200 MG Per 10 ML Injection

DRUG

Ferinject

DRUG

Contacts

maya Wolf, MD

CONTACT

972507887800 mayaw@gmc.gov.il

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

NCT05304442

Anemia, Iron DeficiencyUterine Bleeding

View study

COMPLETEDPHASE3

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

NCT05085275

Anemia, Iron DeficiencyHyperphosphatemia+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 6, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Inclusion Criteria

Exclusion Criteria

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)

A Clinical Study to Check the Safety and Effectiveness of Botanical Extract Standardized for Iron + Vitamin C and Botanical Extract Standardized for Iron in Adult Human Subjects with Anemia or Iron-deficiency Anemia

The Effect of Vitamin C for Iron Supplementation During Pregnancy with Risk of Anemia

Iron Status in Autism Spectrum Disorders